Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.
Megan Holsopple, PharmD, BCPS
Advertisement
Articles by Megan Holsopple, PharmD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
TACTI-004 Trial Studying Eftilagimod Alfa With Pembrolizumab in Advanced NSCLC to Begin Evaluation
3
Young Women With Symptomatic Long COVID At Higher Risk of POTS
4
UConn’s Medical Writing Certificate Program: It’s Just "Write"
5
